Progress has been made in resource-limited countries in treating acute lymphoblastic leukemia, but advances in solid malignancies have been slower. Multidisciplinary care coordination is challenging, assessing adherence to guidelines through quality improvement initiatives is essential.
INTRODUCTION
Survival for children in low-and middle-income countries (LMIC) is compromised by a multitude of factors. [1] [2] [3] Adaptations of protocols to fit the resource requirements of centers in LMIC have shown great success in improving outcomes for acute lymphoblastic leukemia 4 ; however, the progress in treating solid tumors has lagged behind. 5, 6 The complexity of the multidisciplinary care required to treat solid malignancies poses many challenges to the successful implementation of modern treatments. 7 Although most elements of care may be available, the difficulties of coordinating multidisciplinary protocols are amplified in resource-limited settings and often result in treatment delays and deviations.
Radiation therapy (RT) is one crucial, and complex, component of solid tumor treatment. In LMIC, it is estimated that over 80% of children presenting with solid malignancies will require RT to achieve Abbreviations: LMIC, low/middle-income countries; NPC, nasopharyngeal carcinoma; RB, retinoblastoma; RMS, rhabdomyosarcoma; RT, radiation therapy; WT, Wilms tumor cure. 1 The key components of RT delivery must be analyzed in order to ensure quality treatment.
As a pilot quality improvement study, we performed a retrospective case-series review of children with a solid neoplasm treated in a middle-income country with the aim of characterizing deviations from the adapted treatment guidelines. A secondary aim was to initiate the development of an instrument that would allow performing similar evaluations of adherence to RT protocols by other programs.
METHODS
In a retrospective case-series, we reviewed the medical records of Data from patient records were collected for the following variables: total dosage of radiation delivered, number of fields irradiated, time from diagnosis to initiation of treatment, and duration of treatment. Treatment received was compared to the adapted protocols for each patient's specific disease and stage. These adapted protocols were adjusted from published, peer-reviewed regimens. [8] [9] [10] [11] [12] [13] [14] The duration of treatment is a surrogate for continuity because radiation is delivered in standard dosage/day. The number of fields irradiated was taken as indication of whether or not distant lymph nodes or metastases were irradiated. All fields indicated should be irradiated; all deviations in number of fields were considered for analysis. Differences between treatment and guidelines were recorded, and deviations were defined (Table 1) . Of these 30 patients for whom RT was indicated, 19 completed radiation treatment and 11 (36.67%) did not receive radiation despite its indication (Fig. 1A) . Two of those 11 abandoned therapy before RT initiation. Neither gender, age group, nor primary malignancy was statistically significant risk factors for failure to initiate RT; however, NPC was the only disease for which all patients received radiation.
RESULTS

Forty
Of the 19 patients who received RT, 95% had at least one deviation and 58% had at least two deviations. Timing and continuity were the variables that most frequently had deviations, with 53% and 78% of patients experiencing a deviation in timing and continuity, respectively (Fig. 1B) . Deviations in dosage varied widely by disease as follows: 100% deviations in dose for patients with RB, 71% in RMS, 17% in WT, and 0% in patients with NPC. There were not significant differences between diseases for the amount of deviations for timing, continuity, or fields irradiated.
DISCUSSION
In this pilot study, we evaluated adherence to adapted, disease-specific treatment guidelines for the delivery of RT in a middle-income country to assess one component of the multidisciplinary approach required for the treatment of pediatric solid tumors. While the program continues to work toward improving standards and adherence, as noted by the very low abandonment rate (3 in 49 patients), quality improvement studies are necessary to ensure growth.
Over one-third of patients for whom RT was indicated did not receive radiation. While an in-depth analysis of causation could not be performed due to the retrospective nature of the study and limited available information, the reasons for this lack of adherence are likely multifactorial and range from miscommunication of adapted protocols, to hesitancy in referring patients to RT based on uncertain stage of diagnosis, to parental refusal based on cultural fears about RT. We did not identify any trends by age or disease; however, the difficulties in younger children, such as the necessity of anesthesia and long-term effects on younger patients, remain factors that could increase the risk of poor compliance in the younger population.
Amongst those who received RT, deviations were identified in 95% of the cases. Dosage and fields, the variables that are completely controlled by the medical and radiation oncologists, revealed far fewer deviations overall than timing and continuity, which are multifactorial.
When analyzed by disease, however, RB and RMS were more likely to experience deviations in oncologist-controlled variables as well, while the treatment for patients with NPC was more likely to adhere to guidelines, probably owing to the lack of surgical interventions that would interfere with timing and planning. Interpreting the large number of deviations in timing and continuity is difficult, as these deviations may be affected by family resources, cultural opinion, inconsistent scheduling of pediatric patients at the adult-focused radiation facility, or miscommunication of guidelines. Investigation of travel time to the clinic, family income, and parent education level should be conducted to further clarify the obstacles to consistent, timely, and uninterrupted delivery of RT. Furthermore, delays in scheduling surgery or obtaining pathology results may postpone initiation of RT, and represent additional challenges to coordinating multidisciplinary care for patients with solid malignancies.
One limitation of quality improvement studies is that they are designed to analyze individual programs. These single-center results may be influenced by unique challenges experienced by the individual program; however, trends toward deficiencies in referral to radiation, the deviations in timing and continuity, and the difficulty with consistent radiation dosing reflect ubiquitous challenges and highlight the importance of ongoing monitoring after protocol adaptation. We acknowledge the limitations of our study, including the small sample size; however, our data are meant to bring the attention to the importance of close monitoring of adherence to standards in RT as resourceadapted therapies are developed, and to highlight the need for conducting similar studies. Our tool to gather data on deviations could facilitate the development of a larger, prospective multicenter study to further define the patient and disease-specific variables that influence adherence with RT delivery in children with solid tumors. 
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